Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/28/20
End: 01/28/21
Due: 01/28/22
Phase: N/A
Priority: Normal
Start: 07/08/19
End: 02/10/20
Due: 02/10/21
Phase: N/A
Priority: Normal
Start: 08/29/23
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 06/07/22
End: 03/21/23
Due: 03/21/24
Phase: N/A
Priority: Normal
Start: 10/16/17
End: 03/19/18
Due: 03/19/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase 1 XG005-03 Topical Study | NCT04283474 | Xgene Pharmaceutical Group | user2@example.com | None | 2020-02-28 | 2021-01-28 | 2022-01-28 | - | - | 2025-07-14 |
| Phase 1 Pharmacokinetics, Safety, and Tolerability Study | NCT04067947 | Xgene Pharmaceutical Group | user2@example.com | None | 2019-07-08 | 2020-02-10 | 2021-02-10 | - | - | 2025-07-14 |
| XG005 for Pain Control in Subjects Undergoing Bunionectomy | NCT06017999 | Xgene Pharmaceutical Group | user2@example.com | None | 2023-08-29 | 2024-09-30 | 2025-09-30 | - | - | 2025-07-14 |
| A Study of Topical XG004 in Participants With Osteoarthritis of the Knee | NCT05454020 | Xgene Pharmaceutical Group | user2@example.com | None | 2022-06-07 | 2023-03-21 | 2024-03-21 | - | - | 2025-07-14 |
| Pharmacokinetics Study of XG005 Capsule | NCT04499209 | Xgene Pharmaceutical Group | user2@example.com | None | 2017-10-16 | 2018-03-19 | 2019-03-19 | - | - | 2025-07-14 |